Compare DARE & ZSTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DARE | ZSTK |
|---|---|---|
| Founded | 2015 | 2019 |
| Country | United States | Canada |
| Employees | N/A | 76 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6M | 20.0M |
| IPO Year | 2014 | N/A |
| Metric | DARE | ZSTK |
|---|---|---|
| Price | $1.77 | $5.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 97.9K | 12.7K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,807,885.00 | N/A |
| Revenue This Year | $3,195.79 | $15.73 |
| Revenue Next Year | $95.92 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.27 | $4.76 |
| 52 Week High | $9.19 | $11.00 |
| Indicator | DARE | ZSTK |
|---|---|---|
| Relative Strength Index (RSI) | 57.18 | 43.58 |
| Support Level | $1.67 | N/A |
| Resistance Level | $1.84 | $9.45 |
| Average True Range (ATR) | 0.13 | 0.73 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 75.93 | 32.20 |
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
ZeroStack Corp is an AI focused asset management company. The company also operates a world-wide pharmaceutical distribution business through its wholly owned subsidiary. ZeroStack is focused on providing exposure to decentralized AI through a concentrated digital asset approach structured to generate yield and fee-based income from staking validators, compute power technology companies, and complementary businesses within the ecosystem and across the wider AI landscape.